IBDEI0Y9 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34477,0)
 ;;=I50.32^^125^1634^48
 ;;^UTILITY(U,$J,358.3,34477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34477,1,3,0)
 ;;=3^Chr Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,34477,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,34477,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,34478,0)
 ;;=I27.82^^125^1634^49
 ;;^UTILITY(U,$J,358.3,34478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34478,1,3,0)
 ;;=3^Chr Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,34478,1,4,0)
 ;;=4^I27.82
 ;;^UTILITY(U,$J,358.3,34478,2)
 ;;=^338238
 ;;^UTILITY(U,$J,358.3,34479,0)
 ;;=I50.22^^125^1634^50
 ;;^UTILITY(U,$J,358.3,34479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34479,1,3,0)
 ;;=3^Chr Systolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,34479,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,34479,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,34480,0)
 ;;=I42.0^^125^1634^53
 ;;^UTILITY(U,$J,358.3,34480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34480,1,3,0)
 ;;=3^Dilated Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,34480,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,34480,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,34481,0)
 ;;=I10.^^125^1634^54
 ;;^UTILITY(U,$J,358.3,34481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34481,1,3,0)
 ;;=3^Essential Hypertension
 ;;^UTILITY(U,$J,358.3,34481,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,34481,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,34482,0)
 ;;=I50.9^^125^1634^55
 ;;^UTILITY(U,$J,358.3,34482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34482,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34482,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,34482,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,34483,0)
 ;;=I35.1^^125^1634^60
 ;;^UTILITY(U,$J,358.3,34483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34483,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,34483,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,34483,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,34484,0)
 ;;=I35.0^^125^1634^61
 ;;^UTILITY(U,$J,358.3,34484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34484,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,34484,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,34484,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,34485,0)
 ;;=I35.2^^125^1634^62
 ;;^UTILITY(U,$J,358.3,34485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34485,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,34485,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,34485,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,34486,0)
 ;;=I35.9^^125^1634^58
 ;;^UTILITY(U,$J,358.3,34486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34486,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,34486,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,34486,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,34487,0)
 ;;=I21.4^^125^1634^57
 ;;^UTILITY(U,$J,358.3,34487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34487,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,34487,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,34487,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,34488,0)
 ;;=I42.8^^125^1634^46
 ;;^UTILITY(U,$J,358.3,34488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34488,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,34488,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,34488,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,34489,0)
 ;;=I20.8^^125^1634^7
 ;;^UTILITY(U,$J,358.3,34489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34489,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,34489,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,34489,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,34490,0)
 ;;=I42.2^^125^1634^56
 ;;^UTILITY(U,$J,358.3,34490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34490,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,34490,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,34490,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,34491,0)
 ;;=I35.8^^125^1634^59
 ;;^UTILITY(U,$J,358.3,34491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34491,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,34491,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,34491,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,34492,0)
 ;;=I42.5^^125^1634^65
 ;;^UTILITY(U,$J,358.3,34492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34492,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,34492,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,34492,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,34493,0)
 ;;=I05.8^^125^1634^69
 ;;^UTILITY(U,$J,358.3,34493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34493,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,34493,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,34493,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,34494,0)
 ;;=I08.8^^125^1634^70
 ;;^UTILITY(U,$J,358.3,34494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34494,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,34494,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,34494,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,34495,0)
 ;;=I47.9^^125^1634^63
 ;;^UTILITY(U,$J,358.3,34495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34495,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,34495,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,34495,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,34496,0)
 ;;=I05.1^^125^1634^66
 ;;^UTILITY(U,$J,358.3,34496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34496,1,3,0)
 ;;=3^Rheumatic Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,34496,1,4,0)
 ;;=4^I05.1
 ;;^UTILITY(U,$J,358.3,34496,2)
 ;;=^269568
 ;;^UTILITY(U,$J,358.3,34497,0)
 ;;=I05.0^^125^1634^67
 ;;^UTILITY(U,$J,358.3,34497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34497,1,3,0)
 ;;=3^Rheumatic Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,34497,1,4,0)
 ;;=4^I05.0
 ;;^UTILITY(U,$J,358.3,34497,2)
 ;;=^5007041
 ;;^UTILITY(U,$J,358.3,34498,0)
 ;;=I05.9^^125^1634^68
 ;;^UTILITY(U,$J,358.3,34498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34498,1,3,0)
 ;;=3^Rheumatic Mitral Valve Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34498,1,4,0)
 ;;=4^I05.9
 ;;^UTILITY(U,$J,358.3,34498,2)
 ;;=^5007044
 ;;^UTILITY(U,$J,358.3,34499,0)
 ;;=I21.3^^125^1634^71
 ;;^UTILITY(U,$J,358.3,34499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34499,1,3,0)
 ;;=3^STEMI Myocardial Infarction,Unspec Site
 ;;^UTILITY(U,$J,358.3,34499,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,34499,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,34500,0)
 ;;=I44.30^^125^1634^43
 ;;^UTILITY(U,$J,358.3,34500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34500,1,3,0)
 ;;=3^Atrioventricular Block,Unspec
 ;;^UTILITY(U,$J,358.3,34500,1,4,0)
 ;;=4^I44.30
 ;;^UTILITY(U,$J,358.3,34500,2)
 ;;=^5007204
 ;;^UTILITY(U,$J,358.3,34501,0)
 ;;=I50.40^^125^1634^51
 ;;^UTILITY(U,$J,358.3,34501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34501,1,3,0)
 ;;=3^Combined Systolic & Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34501,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,34501,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,34502,0)
 ;;=I50.30^^125^1634^52
 ;;^UTILITY(U,$J,358.3,34502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34502,1,3,0)
 ;;=3^Diastolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34502,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,34502,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,34503,0)
 ;;=I50.20^^125^1634^72
 ;;^UTILITY(U,$J,358.3,34503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34503,1,3,0)
 ;;=3^Systolic Congestive Hrt Failure,Unspec
 ;;^UTILITY(U,$J,358.3,34503,1,4,0)
 ;;=4^I50.20
 ;;^UTILITY(U,$J,358.3,34503,2)
 ;;=^5007239
 ;;^UTILITY(U,$J,358.3,34504,0)
 ;;=I20.0^^125^1634^73
 ;;^UTILITY(U,$J,358.3,34504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34504,1,3,0)
 ;;=3^Unstable Angina
 ;;^UTILITY(U,$J,358.3,34504,1,4,0)
 ;;=4^I20.0
 ;;^UTILITY(U,$J,358.3,34504,2)
 ;;=^5007076
 ;;^UTILITY(U,$J,358.3,34505,0)
 ;;=M32.12^^125^1634^64
